Targeted delivery of insulin-modified immunoliposomes in vivo

Journal of Liposome Research

Volumn 19, Issue 2, 2009, Pages 116-121

  Yang, Zhiwen ^a   Yang, Muhua ^a   Xiahou, Guolun ^a   Peng, Jinnian ^a   Zhang, Jian ^a  

^a GANNAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOLIPOSOME; INSULIN; LIPOSOME; RALOXIFENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CIRCULATION TIME; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; ANIMAL; COMPARATIVE STUDY; METABOLISM; NEOPLASMS; TISSUE DISTRIBUTION;

ANIMALS; DRUG DELIVERY SYSTEMS; INSULIN; LIPOSOMES; MICE; NEOPLASMS; RALOXIFENE; TISSUE DISTRIBUTION;

EID: 70350616335     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802601792     Document Type: Article

References (35)

1. Cheng, W. W., and Allen, T. M. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv. J Contr Rel. 2008;126:50-58.
2. Datta, S. R., Brunet, A., and Greenberg, M. E. Cellular survival:a play in three Akts. Genes Dev. 1999;13:2905-2927.
3. Denley, A., Wallace, J. C., Cosgrove, L. J., and Forbes, B. E. The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review. Horm Metab Res. 2003;35:778-785.
4. Douglas, R. S., Gianoukakis, A. G., Kamat, S., and Smith, T. J. Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. J Immunol. 2007;178:3281-3287.
5. Elbayoumi, T. A., and Torchilin, V. P. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. Eur J Pharm Sci. 2007;32:159-168.
6. Frittitta, L., Cerrato, A., Sacco, M. G., Weidner, N., Goldfine, I. D., and Vigneri, R. The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice. Breast Cancer Res Treat. 1997;45:141-147.
7. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Mandelbaum- Shavit, F., Qazen, M. M., et al. Targeting folate receptor with folate linked to extremities of poly(ethyleneglycol)-grafted liposomes: in vitro studies. Bioconj Chem. 1999;10:289-298.
8. Gabizon, A., Horowitz, A. T., Goren, D., Tzemach, D., Shmeeda, H., and Zalipsky, S. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing ice. Clin Cancer Res. 2003;17:6551-6559.
9. Gherzi, R., Sesti, G., Andraghetti, G., De Pirro, R., Lauro, R., Adezati, L., et al. An extracellular domain of the insulin receptor beta-subunit with regulatory function on protein-tyrosine kinase. J Biol Chem. 1989;264:8627-13865
10. Haluska, P., Carboni, J. M., Loegering, D. A., Lee, F. Y., Wittman, M., Saulnier, M. G., et al. In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417. Cancer Res. 2006;66:362-371.
11. Han, H. D., Lee, A., Song, C. K., Hwang, T., Seong, H., Lee, C. O., et al. In vivo distribution and antitumor activity of heparin-stabilized doxorubicin-loaded liposomes. Int J Pharm. 2006;313:181-188.
12. Hatakeyama, H., Akita, H., Ishida, E., Hashimoto, K., Kobayashi, H., Aoki, T., et al. Tumor targeting of doxorubicin by anti-MT1- MMP antibody-modified PEG liposomes. Int J Pharm. 2007;342:194-200.
13. Iden, D. L., and Allen, T. M. In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochim Biophys Acta. 2001;1513;207-216.
14. Kennel, S. J., Woodward, J. D., Rondinone, A. J., Wall, J., Huang,Y.,and Mirzadeh,S. The fate of MAb-targeted Cd(125m)Te/ZnS nanoparticles in vivo. Nucl Med Biol. 2008;35:501-514.
15. Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., et al. Antibody targeting of long- circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. Cancer Res. 2006;66:6732-6740.
16. Klibanov, A. L., Maruyama, K., Torchilin, V. P., and Hunag, L. Amphipathic polyethy-lenglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990;268:235-237.
17. Kojima, N., Biao, L., Nakayama, T., Ishii, M., Ikehara, Y., and Tsujimura, K. Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity. J Contr Rel. 2008;129:26-32.
18. Liu, W. S., Huang, Y., and Zhang, Z. R. Synthesis and characterization of the tumor targeting mitoxantrone-insulin conjugate. Arch Pharm Res. 2003;26:892-897.
19. Lukyanov, A. N., Elbayoumi, T. A., Chakilam, A. R., and Torchilin, V. P. Tumor- targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. J Contr Rel. 2004;100:135-144.
20. Mulligan, C., Rochford, J., Denyer, G., Stephens, R., Yeo, G., Freeman, T., et al. Microarray analysis of insulin and insulin-like growth factor- 1 (IGF-1) receptor signaling reveals the selective up-regulation of the mitogen heparin-binding EGF-like growth factor by IGF-1. J Biol Chem. 2002;277:42480-42487.
21. Osborne, C. K., Bolan, G., Monaco, M. E., and Lippman, M. E. Hormone responsive human breast cancer in longterm tissue culture: effect of insulin. Proc Natl Acad Sci. 1976;73:4536-4540.
22. Palakurthi, S., Wilson, J., McQuarrie, S. A., Suresh, M. R., Mercer, J. R., and Miller, G. G. Target specificity of 188Re-labeled B27.1 monoclonal antibodies to ovarian cancer cells in vivo. In Vivo. 2008;22:321-326.
23. Papa, V., and Belfiore, A. Insulin receptors in breast cancer: biological and clinical role. J Endocrinol Invest. 1996;19:324-333.
24. Park, J. W., Hong, K., Kirpotin, D. B., Colbern, G., Shalaby, R., Baselga, J., et al. Anti-HER2 immunoliposomes: enhanced effi cacy attributable to targeted delivery. Clin Cancer Res. 2002;8:1172-1181.
25. Poznasky, M. J., Singh, R., Singh, B., and Fantus, G. Insulin: carrier potential for enzyme and durg therapy. Science. 1984;223:1304-1306.
26. Peterson, G. A simplification of the protein assay method of Lowry et al., which is generally more applicable. Anal Biochem. 1977;83:346-356.
27. Sachdev, D., Singh, R., Fujita-Yamaguchi, Y., and Yee D. Downregulation of insulin receptor by antibodies against the type I insulin-like growth factor receptor: implications for anti-insulin- like growth factor therapy in breast cancer. Cancer Res. 2006;66:2391-2402.
28. Sapra, P., and Allen, T. M. Internalizing antibodies are necessary for improved therapeutic efficacy of antibody-targeted liposomal drugs. Cancer Res. 2002;62:7190-7194.
29. Sun, W., Zou, W., Huang, G., Li, A., and Zhang, N. Pharmacokinetics and targeting property of TFu-loaded liposomes with different sizes after intravenous and oral administration. J Drug Target. 2008;16:357-365.
30. Tanaka, S., Sugimachi, K., and Maehara, S. Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma. Surgery. 2002;131:142-147.
31. Taylor, S. I., and Marcus-Samuels, B. Anti-receptor antibodies mimic the effect of insulin to down-regulate insulin receptors in cultured human lymphoblastoid (IM-9) cells. J Clin Endocrinol Metab. 1984;58:182-186.
32. Van Obberghen, E., Ksauga, M., Le Cam, A., Hedo, J. A., Itin, A., and Harrison, L. C. Biosynthetic labeling of insulin receptor: studies of subunits in cultured human IM-9 lymphocytes. Proc Natl Acad Sci. 1981;78:1052-1056.
33. Wang,Y., Hailey, J., Williams, D., Wang, Y., Lipari, P., Malkowski, M., et al. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody. Mol Cancer Ther. 2005;4:1214-1221.
34. Yokoe, J., Sakuragi, S., Yamamoto, K., Teragaki, T., Ogawara, K., Higaki, K., Katayama, N., et al. Albumin-conjugated PEG liposome enhances tumor distribution of liposomal doxorubicin in rats. Int J Pharm. 2008;353:28-34.
35. Zhao, W., Chen, H., Xu, H., Moore, E., Meiri, N., Quon, M. J., et al. Brain insulin receptors and spatial memory. Correlated changes in gene expression, tyrosine phosphorylation, and signaling molecules in the hippocampus of water maze trained rats. J Biol Chem. 1999;274:34893-34902.